top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

8.810 +0.090 (+1.03%)
Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
Expands programmatic access to 800,000 verified prescribers directly in the EHR workflow, making OptimizeRx’s point of care inventory directly available to advertisers using The Trade Desk 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
New functionality helps DSPs and agency planners create deterministic HCP and consumer audiences faster, using one single workflow 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance ↗
Via Chartmill
OptimizeRx Corp (NASDAQ:OPRX) Beats Q4 Earnings Estimates but Offers Cautious 2026 Outlook ↗
Via Chartmill
News headline image
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
Experienced pharmaceutical and healthcare executive joins advisory board to help accelerate innovation and strengthen life sciences marketing technology 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript ↗
AI software revenue grew 25% despite overall quarterly decline from customer inactivity. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
OptimizeRx Q2 Earnings Call Highlights ↗
OptimizeRx (NASDAQ:OPRX) reported second-quarter fiscal 2026 revenue of $20.5 million, down 30% from $29.2 million a year earlier, while adjusted EBITDA totaled $4.9 million, management said on its... 
Via MarketBeat
Topics Earnings
News headline image
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
Leading pharmaceutical marketing executive joins leadership team to accelerate innovation and strengthen partnerships across the life sciences industry 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
Enhanced technology delivers brand savings offers directly within the prescribing workflow, when HCP intent is highest 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
Patent-pending, embeddable NLAB technology enables pharma and agency marketers to build custom, verified HCP audiences using natural-language prompts 
From OptimizeRx Corporation
Via GlobeNewswire
MissionIRNewsBreaks – OptimizeRx Corp. (NASDAQ: OPRX) Secures $35 Million Senior Credit Facility
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
Powered by OptimizeRx’s new programmatic infrastructure, collaboration expands access to premium point of care inventory for life sciences marketers 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx (OPRX) Q1 2026 Earnings Transcript ↗
OptimizeRx (OPRX) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
OptimizeRx Q1 Earnings Call Highlights ↗
OptimizeRx (NASDAQ:OPRX) reported first-quarter fiscal 2026 results that topped consensus expectations, while management lowered its full-year revenue outlook, citing continued caution among life... 
Via MarketBeat
Topics Earnings
News headline image
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
Expands life sciences marketers’ reach at the validated point of care, enabling DSPs to directly integrate with OptimizeRx’s trusted EHR network for the first time 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Discover the top movers in Wednesday's pre-market session. ↗
Via Chartmill
News headline image
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript ↗
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
Whetstone Capital Exits GitLab as Enterprises Rethink AI-Driven Software Development Tools ↗
Whetstone Capital Advisors has sold its stake in GitLab, a unified DevOps platform competing in the fast-changing market for AI-assisted coding and secure software delivery. As companies look at... 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Whetstone Dumps 79,000 monday.com Shares Worth $15.3 Million ↗
This cloud-based software provider serves organizations worldwide with modular tools for work management and collaboration. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page